# Assessment and Management of Chronic Dyspepsia in Eastern Uganda

> **NCT04525664** · EARLY_PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 376 (actual)

## Conditions studied

- Helicobacter Pylori Infection
- Dyspepsia

## Interventions

- **DRUG:** Clarithromycin 500mg
- **DRUG:** Amoxicillin 1000 MG
- **DRUG:** Omeprazole 40 MG
- **DRUG:** Omeprazole 20 MG Oral Tablet

## Key facts

- **NCT ID:** NCT04525664
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-05-31
- **Final completion:** 2020-06-30
- **Target enrollment:** 376 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04525664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04525664, "Assessment and Management of Chronic Dyspepsia in Eastern Uganda". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04525664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*